AR066783A1 - Proceso para proporcionar un relajante muscular estable a la temperatura a base del componente neurotoxico de toxina botulinica - Google Patents
Proceso para proporcionar un relajante muscular estable a la temperatura a base del componente neurotoxico de toxina botulinicaInfo
- Publication number
- AR066783A1 AR066783A1 ARP080102287A ARP080102287A AR066783A1 AR 066783 A1 AR066783 A1 AR 066783A1 AR P080102287 A ARP080102287 A AR P080102287A AR P080102287 A ARP080102287 A AR P080102287A AR 066783 A1 AR066783 A1 AR 066783A1
- Authority
- AR
- Argentina
- Prior art keywords
- stable
- muscle relaxant
- providing
- neurotoxic component
- temperature based
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
- A61K38/4893—Botulinum neurotoxin (3.4.24.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
La presente invencion proporciona un proceso para proporcionar un relajante muscular, a temperaturas por encima de 6°C, con preferencia por encima de 25°C, donde dicho relajante muscular es una solucion reconstituida que comprende el componente neurotoxico de toxina botulínica libre de proteínas formadoras de complejos, el cual exhibe por lo menos una de las siguientes características, con más preferencia todas las características de la a) a la d): a) Es estable a temperaturas de almacenamiento por encima de 20°C, b) Es estable en presencia de conservantes y/o analgésicos, c) Es resistente contra ciclos de ôcongelacion y descongelacionö, d) Es estable si se almacena en envases de diferentes materiales.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US93262407P | 2007-06-01 | 2007-06-01 | |
EP07010912A EP1997509A1 (en) | 2007-06-01 | 2007-06-01 | Process for providing a temperature-stable muscle relaxant on the basis of the neurotoxic component of botulinum toxin |
US99885807P | 2007-10-12 | 2007-10-12 | |
EP07020025A EP2048156A1 (en) | 2007-10-12 | 2007-10-12 | Process for providing a temperature-stable muscle relaxant on the basis of the neurotoxic component of botulinum toxin |
Publications (1)
Publication Number | Publication Date |
---|---|
AR066783A1 true AR066783A1 (es) | 2009-09-09 |
Family
ID=40074591
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP080102286A AR066782A1 (es) | 2007-06-01 | 2008-05-30 | Proceso para proporcionar un relajante muscular estable a la temperatura a base del componente neurotoxico de la oxina botulinica en forma solida |
ARP080102287A AR066783A1 (es) | 2007-06-01 | 2008-05-30 | Proceso para proporcionar un relajante muscular estable a la temperatura a base del componente neurotoxico de toxina botulinica |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP080102286A AR066782A1 (es) | 2007-06-01 | 2008-05-30 | Proceso para proporcionar un relajante muscular estable a la temperatura a base del componente neurotoxico de la oxina botulinica en forma solida |
Country Status (15)
Country | Link |
---|---|
US (2) | US20090010965A1 (es) |
EP (2) | EP2164861A1 (es) |
JP (2) | JP2010529000A (es) |
KR (2) | KR20100020972A (es) |
CN (2) | CN101720331A (es) |
AR (2) | AR066782A1 (es) |
AU (2) | AU2008256419A1 (es) |
BR (2) | BRPI0812245A2 (es) |
CA (2) | CA2686637A1 (es) |
IL (2) | IL202129A0 (es) |
MX (2) | MX2009012990A (es) |
RU (1) | RU2009149604A (es) |
TW (2) | TW200914039A (es) |
WO (2) | WO2008145359A1 (es) |
ZA (2) | ZA200907875B (es) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8168206B1 (en) | 2005-10-06 | 2012-05-01 | Allergan, Inc. | Animal protein-free pharmaceutical compositions |
US10792344B2 (en) | 2006-06-29 | 2020-10-06 | Merz Pharma Gmbh & Co. Kgaa | High frequency application of botulinum toxin therapy |
AR061669A1 (es) | 2006-06-29 | 2008-09-10 | Merz Pharma Gmbh & Co Kgaa | Aplicacion de alta frecuencia de terapia con toxina botulinica |
RU2011125775A (ru) | 2008-12-31 | 2013-02-10 | Реванс Терапьютикс, Инк. | Составы на основе ботулотоксина для инъекции |
US20100184685A1 (en) * | 2009-01-19 | 2010-07-22 | Zavala Jr Gerardo | Systems and methods for treating post- operative, acute, and chronic pain using an intra-muscular catheter administrated combination of a local anesthetic and a neurotoxin protein |
CA2751311C (en) * | 2009-02-19 | 2019-08-06 | Merz Pharma Gmbh & Co. Kgaa | Means and methods for manufacturing highly pure neurotoxin |
EP2248518B1 (en) * | 2009-04-17 | 2013-01-16 | Merz Pharma GmbH & Co. KGaA | Formulation for stabilizing proteins, peptides or mixtures thereof. |
CA2757637C (en) * | 2009-04-27 | 2017-10-24 | Merz Pharma Gmbh & Co. Kgaa | Means and methods for the determination of the amount of neurotoxin polypeptide and of its catalytic and proteolytic activities |
JP6043627B2 (ja) | 2009-06-25 | 2016-12-14 | ルバンス セラピュティックス インク.Revance Therapeutics,Inc. | アルブミン非含有ボツリヌス毒素製剤 |
HUE041599T2 (hu) * | 2009-10-21 | 2019-05-28 | Revance Therapeutics Inc | Eljárások és rendszerek nem-komplexált botulinum neurotoxin tisztítására |
EP3241547B1 (en) * | 2011-03-31 | 2020-05-20 | Medy-Tox Inc. | Lyophilized preparation of botulinum toxin |
KR101135486B1 (ko) * | 2011-05-25 | 2012-04-13 | 함종욱 | 보툴리눔 에이형 독소의 액상제품 |
KR101357999B1 (ko) * | 2012-03-20 | 2014-02-03 | 함종욱 | 보툴리눔 에이형 독소의 액상제품 |
CN107106780B (zh) * | 2014-12-23 | 2020-10-16 | 莫茨制药有限及两合公司 | 肉毒杆菌毒素预填充式容器 |
JP6813492B2 (ja) * | 2015-02-03 | 2021-01-13 | メルツ ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディト ゲゼルシャフト アウフ アクティーン | ボツリヌス毒素充填済み容器 |
EP3070539A1 (fr) * | 2015-03-17 | 2016-09-21 | Omega SA | Montre-bracelet comprenant un cadran muni d'index lumineux |
WO2018038301A1 (en) * | 2016-08-26 | 2018-03-01 | Hugel Inc. | Stabilized liquid formulation of botulinum toxin and preparation method thereof |
MX2020014330A (es) | 2018-12-26 | 2021-03-09 | Caregen Co Ltd | Composicion para relajacion muscular. |
WO2020138674A1 (ko) | 2018-12-26 | 2020-07-02 | (주)케어젠 | 근육 이완용 조성물 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5756468A (en) * | 1994-10-13 | 1998-05-26 | Wisconsin Alumni Research Foundation | Pharmaceutical compositions of botulinum toxin or botulinum neurotoxin and methods of preparation |
TW574036B (en) * | 1998-09-11 | 2004-02-01 | Elan Pharm Inc | Stable liquid compositions of botulinum toxin |
DE19925739A1 (de) * | 1999-06-07 | 2000-12-21 | Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh | Therapeutikum mit einem Botulinum-Neurotoxin |
US20030118598A1 (en) * | 2000-02-08 | 2003-06-26 | Allergan, Inc. | Clostridial toxin pharmaceutical compositions |
AU2003231878A1 (en) * | 2002-05-31 | 2003-12-19 | Solux Corporation | Pharmaceutical preparation of botulinum neurotoxin, methods of synthesis and methods of clinical use |
EP1786459B1 (en) * | 2004-07-26 | 2014-02-12 | Merz Pharma GmbH & Co. KGaA | Therapeutic composition whit a botulinum neurotoxin |
DE102004043009A1 (de) * | 2004-09-06 | 2006-03-23 | Toxogen Gmbh | Transportprotein zum Einbringen chemischer Verbindungen in Nervenzellen |
DE102005019302A1 (de) | 2005-04-26 | 2006-11-16 | Toxogen Gmbh | Carrier zum Targeting von Nervenzellen |
AU2006257411B2 (en) * | 2005-06-17 | 2010-07-22 | Merz Pharma Gmbh & Co. Kgaa | Device and method for the production of biologically active compounds by fermentation |
US8323666B2 (en) * | 2005-08-01 | 2012-12-04 | Allergan, Inc. | Botulinum toxin compositions |
AR061669A1 (es) * | 2006-06-29 | 2008-09-10 | Merz Pharma Gmbh & Co Kgaa | Aplicacion de alta frecuencia de terapia con toxina botulinica |
-
2008
- 2008-05-28 AU AU2008256419A patent/AU2008256419A1/en not_active Abandoned
- 2008-05-28 RU RU2009149604/15A patent/RU2009149604A/ru not_active Application Discontinuation
- 2008-05-28 CA CA002686637A patent/CA2686637A1/en not_active Abandoned
- 2008-05-28 KR KR1020097026300A patent/KR20100020972A/ko not_active Application Discontinuation
- 2008-05-28 WO PCT/EP2008/004254 patent/WO2008145359A1/en active Application Filing
- 2008-05-28 CA CA002686642A patent/CA2686642A1/en not_active Abandoned
- 2008-05-28 JP JP2010509731A patent/JP2010529000A/ja active Pending
- 2008-05-28 MX MX2009012990A patent/MX2009012990A/es not_active Application Discontinuation
- 2008-05-28 KR KR1020097026298A patent/KR20100020971A/ko not_active Application Discontinuation
- 2008-05-28 BR BRPI0812245-8A2A patent/BRPI0812245A2/pt not_active IP Right Cessation
- 2008-05-28 WO PCT/EP2008/004253 patent/WO2008145358A1/en active Application Filing
- 2008-05-28 CN CN200880018452A patent/CN101720331A/zh active Pending
- 2008-05-28 JP JP2010509730A patent/JP2010528999A/ja active Pending
- 2008-05-28 CN CN200880018442A patent/CN101687018A/zh active Pending
- 2008-05-28 EP EP08758837A patent/EP2164861A1/en not_active Withdrawn
- 2008-05-28 BR BRPI0812322-5A2A patent/BRPI0812322A2/pt not_active IP Right Cessation
- 2008-05-28 AU AU2008256418A patent/AU2008256418A1/en not_active Abandoned
- 2008-05-28 MX MX2009012570A patent/MX2009012570A/es not_active Application Discontinuation
- 2008-05-28 EP EP08758836A patent/EP2170375A1/en not_active Withdrawn
- 2008-05-29 US US12/154,982 patent/US20090010965A1/en not_active Abandoned
- 2008-05-29 US US12/154,983 patent/US20090028906A1/en not_active Abandoned
- 2008-05-30 TW TW097120349A patent/TW200914039A/zh unknown
- 2008-05-30 AR ARP080102286A patent/AR066782A1/es not_active Application Discontinuation
- 2008-05-30 AR ARP080102287A patent/AR066783A1/es not_active Application Discontinuation
- 2008-05-30 TW TW097120348A patent/TW200902050A/zh unknown
-
2009
- 2009-11-10 ZA ZA2009/07875A patent/ZA200907875B/en unknown
- 2009-11-10 ZA ZA2009/07874A patent/ZA200907874B/en unknown
- 2009-11-15 IL IL202129A patent/IL202129A0/en unknown
- 2009-11-15 IL IL202130A patent/IL202130A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP2170375A1 (en) | 2010-04-07 |
WO2008145358A1 (en) | 2008-12-04 |
TW200914039A (en) | 2009-04-01 |
ZA200907875B (en) | 2010-11-24 |
AU2008256419A1 (en) | 2008-12-04 |
AR066782A1 (es) | 2009-09-09 |
KR20100020971A (ko) | 2010-02-23 |
MX2009012570A (es) | 2010-03-15 |
TW200902050A (en) | 2009-01-16 |
ZA200907874B (en) | 2011-03-30 |
AU2008256418A1 (en) | 2008-12-04 |
BRPI0812322A2 (pt) | 2014-11-25 |
BRPI0812245A2 (pt) | 2014-10-21 |
EP2164861A1 (en) | 2010-03-24 |
RU2009149604A (ru) | 2011-07-20 |
US20090028906A1 (en) | 2009-01-29 |
CN101720331A (zh) | 2010-06-02 |
CA2686642A1 (en) | 2008-12-04 |
JP2010529000A (ja) | 2010-08-26 |
MX2009012990A (es) | 2010-04-01 |
US20090010965A1 (en) | 2009-01-08 |
IL202130A0 (en) | 2010-06-16 |
JP2010528999A (ja) | 2010-08-26 |
CA2686637A1 (en) | 2008-12-04 |
WO2008145359A1 (en) | 2008-12-04 |
CN101687018A (zh) | 2010-03-31 |
IL202129A0 (en) | 2010-06-16 |
KR20100020972A (ko) | 2010-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR066783A1 (es) | Proceso para proporcionar un relajante muscular estable a la temperatura a base del componente neurotoxico de toxina botulinica | |
TR200706710U (tr) | Elektroluminesans donatılmış eşya. | |
ECSP11011541A (es) | Antagonistas de la trayectoria hedgehog de ftalazina disustituida | |
BRPI0615347A2 (pt) | toleráncia ao estresse em plantas | |
CY1118508T1 (el) | Συνθεση υδατανθρακων λαμβανομενη απο μεσογειακους καρπους | |
WO2006134190A3 (es) | Agentes y métodos basados en el uso del dominio eda de la fibronectina | |
TW200606210A (en) | Polythiophene formulations for improving organic light-emitting diodes | |
TW200710198A (en) | Organic electroluminescent device | |
BRPI0716296A2 (pt) | 'composição, artigo, estrutura laminada,dispersão,artigo moldado por injeção ,artigo moldado ,artigo para calçados e peça automotiva | |
MX2011004539A (es) | Jabones espumables antimicrobianos. | |
GB2456466A (en) | Sanitizing surfaces | |
BRPI0607782A2 (pt) | misturas aditivas para artigos agrìcolas | |
BRPI0910964A2 (pt) | método para tratamento da superficie de calçados, bolsas, luvas, outros artigos de couro ou artigos tipo couro, e, aparelho para impregnação de artigos | |
ECSP11011021A (es) | Antagonistas de la via hedgehog de ftalazina disustituida | |
BR112014007306A2 (pt) | artigos extrudados homogêneos feitos a partir de poliuretanos termoplasticamente processáveis com base em poliéster-dióis formados a partir de ácido succínico e de 1,3-propanodiol | |
DE602006009382D1 (de) | Niedrigtemperaturdeckschicht | |
BRPI0514188A (pt) | caramelos duros com perfil organoléptico melhorado, em particular, estáveis em armazenamento | |
WO2010039819A3 (en) | Compositions for use in identification of fungi | |
BRPI0515476A (pt) | maço com preservação do frescor para artigos oblongos | |
PL1941019T3 (pl) | Kompozycja chemiczna i zastosowania | |
BR112015027735A8 (pt) | componente automotivo compreendendo material compósito | |
Helal et al. | Involvement of PVL Producing MRSA in Pneumonia, Cairo, Egypt | |
TH156825A (th) | องค์ประกอบที่ประกอบรวมด้วย c5 และ c6 มอนอแซคคาไรด์ | |
TH1801001624A (th) | สิ่งของขึ้นรูปและวิธีการสำหรับทำการผลิตสิ่งของขึ้นรูป | |
TR200702259U (tr) | Plastik yapıya sahip sandık. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |